Sanofi Signs Agreement to Produce Vaccines in Algeria
08 December 2017 - 10:08PM
Dow Jones News
By Euan Conley
Sanofi SA (SAN.FR) said Friday that it has signed a memorandum
of understanding with the Saidal Group and the Pasteur Institute of
Algeria to create a company to produce vaccines in Algeria.
Under the agreement, the new unit will manufacture three of
Sanofi's most recent vaccines for immunization against a range of
diseases including hepatitis B, diphtheria, whooping cough and
tetanus.
The unit will create 150 new jobs, Sanofi's vaccine subsidiary
said, with an expected production capacity of between 10 million
and 20 million doses a year.
Write to Euan Conley at euan.conley@dowjones.com
(END) Dow Jones Newswires
December 08, 2017 05:53 ET (10:53 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024
